US Stock MarketDetailed Quotes
BHC Bausch Health
- 8.710
- +0.090+1.04%
Close Apr 26 16:00 ET
- 8.660
- -0.050-0.57%
Post 18:59 ET
3.19BMarket Cap-5376P/E (TTM)
8.820High8.575Low2.08MVolume8.620Open8.620Pre Close18.16MTurnover0.68%Turnover RatioLossP/E (Static)366.67MShares11.46052wk High-3.13P/B2.66BFloat Cap5.57052wk Low--Dividend TTM305.04MShs Float34.800Historical High--Div YieldTTM2.84%Amplitude4.000Historical Low8.718Avg Price1Lot Size
Bausch Health Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 241.76%1.03B | -17.89%390M | 122.33%282M | 67.48%206M | 344.44%154M | -151.05%-728M | 1,879.17%475M | -323.94%-1.26B | -68.86%123M | -114.22%-63M |
| Net income from continuing operations | -188.21%-611M | 88.54%-47M | -194.79%-382M | 119.42%27M | -216.67%-209M | 77.37%-212M | -669.44%-410M | 110.99%403M | 76.56%-139M | 89.13%-66M |
| Operating gains losses | 102.72%24M | 107.77%15M | 99.83%-1M | 106.14%7M | 250.00%3M | -17,760.00%-883M | -319.57%-193M | ---574M | ---114M | 83.33%-2M |
| Depreciation and amortization | -9.33%1.26B | -8.61%329M | -10.15%301M | -9.22%315M | -9.38%319M | -10.18%1.39B | -0.83%360M | --335M | --347M | -12.66%352M |
| Deferred tax | 128.98%51M | 342.11%84M | 96.88%-3M | -87.50%-30M | --0 | 21.78%-176M | 121.59%19M | ---96M | ---16M | -492.86%-83M |
| Other non cash items | 110.27%151M | -6.12%46M | 105.60%69M | -104.35%-2M | 111.38%38M | -648.88%-1.47B | 139.84%49M | 16.53%-1.23B | -97.70%46M | -153.03%-334M |
| Change In working capital | -46.97%-582M | -672.73%-170M | 44.98%-148M | -67.77%-203M | -481.25%-61M | -209.38%-396M | 89.86%-22M | -228.05%-269M | -490.32%-121M | -88.57%16M |
| -Change in receivables | -242.11%-195M | 38.71%-19M | -73.68%-231M | 41.11%-53M | -45.18%108M | 75.11%-57M | 40.38%-31M | ---133M | ---90M | 228.33%197M |
| -Change in inventory | -62.63%-322M | -2,400.00%-100M | -10.71%-62M | 50.77%-32M | -75.34%-128M | -1,137.50%-198M | -108.70%-4M | ---56M | ---65M | -108.57%-73M |
| -Change in prepaid assets | -237.88%-223M | -335.29%-148M | -231.25%-21M | -40.00%-21M | 0.00%-33M | -1,550.00%-66M | 17.07%-34M | --16M | ---15M | ---33M |
| -Change in payables and accrued expense | 310.67%158M | 106.38%97M | 272.92%166M | -297.96%-97M | 89.33%-8M | -161.98%-75M | 127.65%47M | ---96M | --49M | -165.22%-75M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 241.76%1.03B | -17.89%390M | 122.33%282M | 67.48%206M | 344.44%154M | -151.05%-728M | 1,879.17%475M | -323.94%-1.26B | -68.86%123M | -114.22%-63M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -607.92%-2.15B | -8.82%-148M | -3,464.15%-1.89B | 48.28%-30M | -39.29%-78M | -174.08%-303M | -70.00%-136M | -53M | -58M | 0.00%-56M |
| Net PPE purchase and sale | 1.38%-215M | -48.48%-98M | 22.22%-42M | 46.15%-28M | -2.17%-47M | 18.96%-218M | 15.38%-66M | ---54M | ---52M | 30.30%-46M |
| Net intangibles purchase and sale | -14.00%-57M | -53.33%-46M | 20.00%-4M | 25.00%-3M | 63.64%-4M | -257.14%-50M | -500.00%-30M | ---5M | ---4M | -450.00%-11M |
| Net business purchase and sale | -4,100.00%-1.89B | 93.33%-3M | ---1.86B | --0 | ---31M | ---45M | ---45M | --0 | --0 | --0 |
| Net investment purchase and sale | -120.00%-1M | ---1M | -66.67%2M | --0 | -300.00%-2M | 225.00%5M | --0 | --6M | ---2M | 133.33%1M |
| Net other investing changes | 0.00%5M | --0 | --4M | ---- | ---- | -99.25%5M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -607.92%-2.15B | -8.82%-148M | -3,464.15%-1.89B | 48.28%-30M | -39.29%-78M | -174.08%-303M | -70.00%-136M | -109.01%-53M | -34.88%-58M | 0.00%-56M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 411.18%1.48B | 71.38%-79M | 5,144.44%1.82B | 80.95%-120M | -130.34%-142M | 68.67%-474M | -200.36%-276M | -36M | -630M | 292.59%468M |
| Net issuance payments of debt | 256.53%1.58B | 78.65%-57M | 9,265.00%1.87B | 91.22%-111M | -124.75%-124M | 24.63%-1.01B | -194.01%-267M | --20M | ---1.26B | 346.80%501M |
| Net common stock issuance | --0 | --0 | --0 | ---- | ---- | --675M | --0 | --0 | ---- | ---- |
| Net other financing activities | 23.74%-106M | 27.50%-58M | -240.00%-21M | 78.05%-9M | 45.45%-18M | 19.65%-139M | -788.89%-80M | --15M | ---41M | 17.50%-33M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 411.18%1.48B | 71.38%-79M | 5,144.44%1.82B | 80.95%-120M | -130.34%-142M | 68.67%-474M | -200.36%-276M | 96.89%-36M | -62.37%-630M | 292.59%468M |
| Net cash flow | ||||||||||
| Beginning cash position | -72.11%591M | 56.94%780M | -68.71%588M | -78.41%531M | -72.11%591M | 16.69%2.12B | -73.90%497M | -2.03%1.88B | 26.35%2.46B | 16.69%2.12B |
| Current changes in cash | 124.05%362M | 158.73%163M | 115.46%209M | 109.91%56M | -118.91%-66M | -567.39%-1.51B | -71.23%63M | -26,940.00%-1.35B | -1,469.44%-565M | 142.36%349M |
| Effect of exchange rate changes | 139.13%9M | -38.71%19M | 43.33%-17M | 106.25%1M | 175.00%6M | -21.05%-23M | 875.00%31M | -233.33%-30M | -328.57%-16M | 38.46%-8M |
| End cash Position | 62.77%962M | 62.77%962M | 56.94%780M | -68.71%588M | -78.41%531M | -72.11%591M | -72.11%591M | -73.90%497M | -2.03%1.88B | 26.35%2.46B |
| Free cash flow | 176.31%760M | -35.09%246M | 117.85%236M | 161.19%175M | 185.83%103M | -187.14%-996M | 742.37%379M | -463.19%-1.32B | -85.53%67M | -132.00%-120M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg